Production (Stage)
MIRA Pharmaceuticals, Inc.
MIRA
$1.40
$0.032.19%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -57.42% | -31.65% | 46.77% | -19.98% | -23.33% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 189.95% | -36.84% | -20.26% | -41.39% | -24.00% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -52.73% | -31.75% | 44.29% | -21.04% | -23.55% |
|
|||||
Total Current Assets | -52.73% | -31.75% | 44.29% | -21.04% | -23.55% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -74.51% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | 0.00% | -57.45% | -11.02% | 35.12% |
Total Assets | -52.10% | -31.49% | 41.48% | -20.83% | -22.78% |
|
|||||
Total Accounts Payable | -86.08% | 4.40% | -11.42% | 22.91% | 18.14% |
Total Accrued Expenses | -- | -- | -- | 0.00% | 0.00% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -74.51% |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -85.32% | 4.40% | -13.03% | 22.18% | 16.82% |
|
|||||
Total Current Liabilities | -85.32% | 4.40% | -13.03% | 22.18% | 16.82% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -85.32% | 4.40% | -13.03% | 22.18% | 16.82% |
|
|||||
Common Stock & APIC | 2.80% | 3.38% | 12.63% | 2.88% | 1.95% |
Retained Earnings | -6.12% | -8.97% | -8.28% | -7.35% | -8.07% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -41.17% | -38.44% | 61.05% | -29.71% | -27.83% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -41.17% | -38.44% | 61.05% | -29.71% | -27.83% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -41.17% | -38.44% | 61.05% | -29.71% | -27.83% |
|